Endologix Announces Temporary Hold on AFX to Resolve a Manufacturing Issue
Dec 27, 2016 12:30 pm UTC| Business
Conference Call Scheduled for 9:00 am ET Today, December 27, 2016 IRVINE, Calif., Dec. 27, 2016 -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced a...
Dec 27, 2016 12:30 pm UTC| Business
CARMIEL, Israel, Dec. 27, 2016 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX) (the “Company”) announced today the confirmation of the recent letter of intent to purchase alfataliglicerase to treat Gaucher...
Dec 27, 2016 12:05 pm UTC| Business
SALT LAKE CITY, Dec. 27, 2016 -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data on the use of Vectra® DA test to predict treatment response in...
DSP Group to Participate at the 19th Annual Needham Growth Conference
Dec 27, 2016 12:00 pm UTC| Business
LOS ALTOS, Calif., Dec. 27, 2016 -- DSP Group®, Inc. (Nasdaq:DSPG), a leading global provider of wireless chipset solutions for converged communications, announced today it will be participating in the 19th Annual...
Dec 27, 2016 12:00 pm UTC| Business
-- First Major Near-Term Milestone Accomplished -- -- Mid-2017 Submission of Biologics License Application (BLA) for Accelerated Approval Progressing as Planned -- MORRIS PLAINS, N.J., Dec. 27, 2016 -- Immunomedics,...
Dec 27, 2016 12:00 pm UTC| Business
SAN DIEGO, Dec. 27, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the launch of Vitaros®, Apricus’ novel...
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene® Mist
Dec 27, 2016 11:00 am UTC| Business
RANCHO CUCAMONGA, Calif., Dec. 27, 2016 -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to its wholly-owned...